13F Portfolios

Pertento Partners LLP: NUTEX HEALTH INC (NUTX): Quarterly 13F Position History

As of Q2 2026, Pertento Partners LLP reported 451,310 shares of NUTEX HEALTH INC (NUTX), worth $77.1M and representing 5.5% of its 13F equity book. Quarter-over-quarter share count change: + 77,340 (+20.7%) . The position first appeared in Q3 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 451,310 +77,340 +20.7% $77.1M 5.5% $170.9
Q1 2026 373,970 +49,548 +15.3% $35.5M 3.8% $95.0
Q4 2025 324,422 +54,001 +20.0% $53.4M 5.9% $164.6
Q3 2025 270,421 $27.9M 3.4% $103.3

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Pertento Partners LLP first disclose a NUTX position in 13F-HR filings?

Pertento Partners LLP first reported NUTEX HEALTH INC (NUTX) on its 13F-HR filing for the period ending 2025-09-30 (Q3 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.

What was Pertento Partners LLP's most recent quarter-over-quarter share-count change in NUTX?

Between Q1 2026 and Q2 2026, Pertento Partners LLP added 77,340 shares of NUTX (+20.7%), bringing the total reported position to 451,310 shares at a market value of $77.1M.

Does the implied price-per-share represent Pertento Partners LLP's cost basis in NUTX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.